Lv4
640 积分 2024-12-14 加入
Understanding and targeting resistance mechanisms in NSCLC
15小时前
已完结
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
23天前
已完结
Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers
23天前
已完结
Acquired resistance to TKIs in solid tumours: learning from lung cancer
23天前
已完结
Understanding and targeting resistance mechanisms in NSCLC
1个月前
已完结
MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2
2个月前
已完结
Single-cell transcriptional profiling uncovers the association between EOMES+CD8+ T cells and acquired EGFR-TKI resistance
3个月前
已完结
Overcoming EGFR-TKI resistance by targeting the tumor microenvironment
3个月前
已完结
ADAM12 promotes the resistance of lung adenocarcinoma cells to EGFR-TKI and regulates the immune microenvironment by activating PI3K/Akt/mTOR and RAS signaling pathways
3个月前
已完结
Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer
3个月前
已完结
皖公网安备34019202002308
